2023

Keynote speaker. 2023. Epidemiology and risk assessment: Reflections on Working Together to Improve Public Health. International Conference on Using Epidemiological Studies in Health Risk Assessments: Relevance, Reliability and Causality. Berlin, Germany. 10 November.

Invited lecturer. 2023. Everything you wanted to know about consulting* - *but were afraid to ask. Lecture, Applied Mathematics and Statistics, The Johns Hopkins University. 15 February

2022

Invited speaker. 2022. “Forever Chemicals” (PFAS) in Breast Milk and Infant Formula: A Global Issue. International Clean-up Conference. Adelaide, Australia. 12 September 2022.

Invited speaker. 2022. PFAS and breast milk: What we don’t know, what we should know. 3rd National PFAS Meeting: Highly Fluorinated Compounds – Environmental Justice and Scientific Discovery. Wilmington, NC. 16 June.

Invited speaker. 2022. PFAS in breast milk in the US and Canada: Mom/infant exposure data gaps. Health Canada Environmental Health Science and Research Bureau. 25 May.

Invited speaker. 2022. Chemical exposures and health effects: Exposure assessment and interpreting epidemiology research. Center for Food Safety and Applied Nutrition (CFSAN). Division of Risk and Decision Analysis. U.S. Food and Drug Administration. 25 March.

Invited speaker. 2022. Epidemiology and exposure assessment: What toxicologists need to know (or remember). Toxicology Forum. 25 January. Virtual Winter Meeting.

2021

LaKind JS. 2021. Current breast milk PFAS levels in the US and Canada: After all this time why don’t we know more? International Society for Exposure Science Annual Meeting (virtual). 1 September.

2020

LaKind JS. 2020. The Matrix: Bridging the gap between epidemiology and risk assessment. International Society for Exposure Science Annual Meeting. Webinar. 22 September.

LaKind JS, Burns CJ. 2020. The Matrix: Bridging the gap between epidemiology and risk assessment. Series of invited webinars (e.g., US EPA OPPP/OPPT, 9 September; Environmental and Occupational Health Sciences (EOHS) Research Seminar Series at The University of Texas Health Science Center at Houston, School of Public Health, 11 September; Johns Hopkins Bloomberg School of Public Health Current Topics in Epidemiology seminar series, 30 September; Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, 9 November; ).

LaKind JS. 2020. Environmental Chemicals in Breast Milk and Formula: Exposure and Risk Assessment Implications. The Society for Birth Defects Research & Prevention Virtual 60th Annual Meeting. 30 June.

LaKind JS, Burns CJ. 2020. Epidemiology, exposure and risk assessment. Texas Commission on Environmental Quality. Webinar. 18 June.

2019

LaKind JS. 2019. Exposure Data Quality Assessments: Why and How? Society for Risk Analysis Annual Conference. Arlington, VA. 11 December.

LaKind JS, Burns CJ. 2019. The Matrix: Bridging the gap between epidemiology and risk assessment. Health Canada. Ottawa, Canada. 4 November.

Invited speaker. 2019. Biomonitoring and epidemiology research on personal care products: We’re not in Kansas anymore. Personal Care Products Council annual Safety Seminar. Philadelphia, PA. 30 October.

Invited lecture (with Dr. Heidi S. Erickson and Dr. Carol Burns). 2019. Strengthening the bonds between Epidemiology and Risk Assessment for Public Health Policy Decisions. The University of Texas Medical Branch at Galveston/Chronic Disease Epidemiology Course. 23 April.

Invited lecture. Conflicts of Interest and Environmental Research. Bioethics course at the Honors College of Florida Atlantic University. 20 March.

LaKind JS, Burns CJ. 2019. Evidence-based environmental decisions: Bridging the gap between epidemiology and risk assessment. SOT RASS/ISES Webinar. 13 February 2019. https://www.toxicology.org/groups/ss/RASS/downloads.asp

2018

LaKind JS. 2018. Exposure Data Quality Assessments: ExpoQual. International Society of Exposure Science/International Society of Environmental Epidemiology. Ottawa, Canada. 28 August.

Invited speaker. 2018. How to assess and interpret biomonitoring data once you have it. Workshop on the Feasibility of Addressing Environmental Exposure Questions Using Department of Defense Biorepositories. The National Academies of Sciences, Engineering and Medicine. Washington, DC. 15 June.

Invited speaker. 2018. Chemical exposures and human health: What can we take away from epidemiology research? Occupational Medicine, Clinical Public Health & Epidemiology Army Public Health Center. Aberdeen Proving Ground, MD. 6 June.

Invited speaker. 2018. Evidence-based environmental decision-making: Problems and progress. Bundesinstitut für Risikobewertung. Berlin, Germany. 24 May.

Invited speaker. 2018. Exposure data quality and environmental epidemiology: Implications for systematic reviews and weight of evidence. Environmental Health Science and Research Bureau (EHSRB) Seminar Series. Health Canada. 21 February. Ottawa, Canada.

Invited speaker. 2018. Exposure data quality in environmental epidemiology: Bad habits and remedies. Université de Montréal Public Health Research Institute. 20 February. Montreal, Canada.

2017

Invited speaker. 2017. Exposure data in environmental epidemiology: limitations and quality assessments. European Food Safety Authority Scientific Conference on the Use of Epidemiological findings in Regulatory Pesticide Risk Assessment. 21 November. Parma Italy.

LaKind JS. 2017. Human exposure to 2,4-D: What do the data tell us? International Society of Exposure Science Annual Meeting. 18 September. Durham NC.

LaKind JS. 2017. Transparent and systematic reviews of exposure data in environmental epidemiology: Approaches and case studies. International Society of Exposure Science Annual Meeting. 17 September. Durham NC.

LaKind JS. 2017. Evaluating strengths and limitation of the exposure data using the Biomonitoring, Environmental Epidemiology, and Short-Lived Chemicals (BEES-C) Instrument: Implications for science and policy. American College of Epidemiology Annual Conference. 25 September. New Orleans, LA.

Invited speaker. 2017. Chemical exposures and health effects: What we know and what we don’t know from epidemiology research. Mid-Atlantic Regional Conference in Occupational and Environmental Medicine. 23 September. Baltimore, MD.

Invited speaker. 2017. Chemical exposures and health effects: What we know and what we don’t know from epidemiology research. Occupational and Environmental Residency Program, Johns Hopkins Bloomberg School of Public Health. 18 September. Baltimore, MD.

LaKind JS. 2017. Human exposure to 2,4-D: What do the data tell us? American Chemical Society 254th Annual Meeting. 21 August. Washington DC.

2016

Invited speaker. 2016. Quality matters in environmental epidemiology: The exposure data we collect versus the data we need. Grand Rounds, University of Maryland School of Medicine. 17 November. Baltimore, MD.

Invited speaker. 2016. Can coating complexities. Workshop – Identifying and Evaluating Alternative Materials: The Case of BPA-Free Can Linings. 4 November. UC Berkeley. Berkeley, CA.

Invited speaker. 2016. Biomonitoring and environmental epidemiology: Implications for personal care products. Personal Care Products Council Safety Workshop. 26 October. Alexandria, VA.

LaKind JS. 2016. Harmonization, transparency, and access: Why we need these in environmental epidemiology [exposure science]. International Society of Exposure Science Annual Meeting. 10 October. Utrecht, The Netherlands.

LaKind JS. 2016. Assessing Biomonitoring Data Quality: The Biomonitoring, Environmental Epidemiology, and Short-Lived Chemicals (BEES-C) Instrument. International Society of Exposure Science Annual Meeting. 12 October. Utrecht, The Netherlands.

Invited speaker. 2016. Cleaning, environmental exposures and respiratory health effects: Issues, challenges and opportunities. 17 June. Advancing the Science Webinar Series. Sponsored by the American Cleaning Institute (ACI), in collaboration with the Toxicology Excellence for Risk Assessment (TERA) Center, University of Cincinnati and Endorsed by the Society of Toxicology.

Invited speaker. 2016. Environmental Epidemiology: The importance of exposure assessment. CropLife America and RISE Spring Conference. 14 April. Arlington, Virginia.

LaKind JS. 2016. Quality Matters in Environmental Epidemiology: The data we collect versus the data we need. 14 March. Society of Toxicology. New Orleans, LA.

Invited speaker. 2016. Biomonitoring and temporality in environmental epidemiology: The data we collect versus the data we need. U.S. Environmental Protection Agency. Temporal Exposure Issues for Environmental Pollutants: Health Effects and Methodologies for Estimating Risk. 27–29 January. Research Triangle Park, NC.

2015

LaKind JS. 2015. Biomonitoring Data in Cumulative Risk Assessment: The Biomonitoring, Environmental Epidemiology, and Short-Lived Chemicals (BEES-C) Instrument. Society for Risk Analysis. 9 December. Arlington, Virginia.

LaKind JS, Naiman DQ. 2015. Temporal trends in BPA exposure in the US from 2003–2012 and factors associated with BPA exposure: Spot samples and urine dilution complicate data interpretation. International Society for Exposure Science. 19 October. Henderson, Nevada.

Invited speaker/panelist. 2015. Exposure Science and Environmental Epidemiology: Problems and Proposed Solutions. ICCA-LRI & US EPA Workshop. What Will Work? Application of New Approaches for Chemical Safety Assessment. June 16-17. New Orleans, Louisiana.

Invited poster presentation. 2015. Issues with quality and harmony in environmental epidemiology: PCBs, BPA and phthalates. ICCA-LRI & US EPA Workshop. What Will Work? Application of New Approaches for Chemical Safety Assessment. June 16-17. New Orleans, Louisiana.

Invited speaker. 2015. Institute of Medicine Workshop on the Interplay between Environmental Exposures and Obesity. March 2-3. Research Triangle Park, NC.

2014

Invited speaker. 2014. The need for more robust data in environmental epidemiology: BPA as a case study. Toxicology Forum. 9 July. Aspen, Colorado.

Invited panelist. 2014. What Is Safe? Integrating Multi-Disciplinary Approaches for Decision Making about the Human Health and Environmental Impacts of Chemicals. ICCA-LRI & JRC Workshop. June 17-18, Lugano, Switzerland.

Speaker. 2014. PCBs and related chemicals in breast milk: What do the data mean for mothers, infants, doctors, regulators and others? Society of Toxicology Annual Meeting. 26 March. Phoenix, Arizona.

2013

Invited speaker. 2013. Endocrine disruptors and obesity, diabetes and heart disease: What does epidemiological research tell us? 15th Cefic-LRI Annual Workshop. 21 November. Brussels, Belgium.

Invited speaker. 2013. Uncertainties in Epidemiology: The Example of Bisphenol A. 2013 Center for Advancing Risk Assessment Science And Policy Workshop. 6 November. Washington DC.

Invited speaker: 2013. Urine and Pool Water: Exposure and Health. World Aquatic Health Conference. 18 October. Indianapolis, Indiana.

Invited speaker. 2013. Cancer Clusters in the USA: What Do the Last 20 Years of State and Federal Investigations Tell Us? Maryland Department of Health and Mental Hygiene Workgroup on Cancer Clusters and Environmental Causes of Cancer. September 10, Baltimore, Maryland.

Invited speaker/panelist. 2013. What is Normal? Biomarkers of Exposure & Effect. ICCA-LRI & NCATS Workshop: What Is Normal? Implications for Chemical Safety Assessment. June 11-12, Santa Fe, New Mexico.

2012

Invited speaker. 2012. 21st Century Solutions for 20th Century Problems: Lessons from 4 decades of environmental epidemiology research. CropLife America & RISE. Spring Conference. Arlington, Virginia. 5 April.

2011

Invited speaker. 2011. Endocrine disruption and risk assessment: The controversial case of bisphenol A. Grand Rounds. Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine. 31 October.

LaKind JS, Levesque J, Dumas P, Bryan S, Clarke J, Naiman DQ. 2011. Can We Compare United States and Canadian Population Exposures from National Biomonitoring Surveys? Bisphenol A (BPA) as a Case Study. International Society for Exposure Science. Baltimore, Maryland. 27 October.

Invited speaker. 2011. Swimming and asthma: What does the current research say? ACI Asthma Science Forum. Arlington, VA. 10 May.

2010

Invited speaker. 2010. Are the kids alright? Strengthening regulatory decision-making in the uncertain world of children’s health research. 12th Cefic LRI Annual Workshop. Brussels, Belgium. 18 November.

Guest Lecturer. 2010. Human Health Risk Assessment Primer. University of Maryland, College Park. 8 November.

Speaker. 2010. The Good, the Bad, and the Volatile: Can We Have Both Healthy Pools and Healthy People? World Aquatic Health Conference. Colorado Springs, CO. 8 October.

Invited speaker. 2010. A Multidisciplinary Approach to Advancing the Science of Neurodevelopmental Testing in Cohorts of Infants and Young Children. Teratology Society’s 50th Annual Meeting. Louisville, Kentucky. Joint TS/Neurobehavioral Teratology Society Symposium on Advancing Neurodevelopmental Evaluation in Children. June 29. Citation: LaKind JS, Youngstrom E, Goodman M, Squibb K, Lipkin PH, Anthony LG, Kenworthy L, Mattison D. 2010. A multidisciplinary approach to advancing the science of neurodevelopmental testing in cohorts of infants and young children. NBTS 34 Neurotoxicology and Teratology 32:505.

Kenworthy L, Anthony LG, Goodman M, LaKind JS, Lipkin PH, Mattison D, Squibb K, Youngstrom E. 2010. Getting the biggest bang for your buck: Choosing neurodevelopmental tests that maximize power, NBTS35 Neurotoxicology and Teratology 32:506.

Anthony LG, Youngstrom E, Kenworthy L, LaKind JS, Goodman M, Squibb K, Lipkin PH, Mattison D. 2010. Threats to study validity: The Flynn Effect, examiner drift, confounders, lost in translation, and other important considerations, NBTS36 Neurotoxicology and Teratology 32:506.

Invited speaker. 2010. Environmental fate of chemicals: Bring babies into the food web. University of Maryland Baltimore County. 10 March.

2009

Invited speaker. 2009. Human milk biomonitoring: data interpretation and risk assessment issues. International Atomic Energy Agency. Vienna, Austria. 16 February.

2008

Invited speaker. 2008. Grand Rounds. Environmental chemicals and breastfeeding infants. The Johns Hopkins School of Medicine. February 6. Baltimore, Maryland.

2007

LaKind, J.S., Squibb, K.S., McElprang, D.O., Blount B.K. Methodologic pilot study of volatile organic compounds (VOCs) in human milk. 2007. 17th Annual Conference of the International Society for Exposure Analysis. October. Durham, North Carolina.

LaKind, J.S., Aylward, L.L., Brunk, C., DiZio, S., Dourson, M., Goldstein, D.A., Kilpatrick, M.E., Krewski, D., Bartels, M., Barton, H.A., Boogaard, P.J., Lipscomb, J., Krishnan, K., Nordberg, M., Okino, M., Tan, Y.-M.., Viau, C., Yager, J.W., Hays, S.M. 2007. Guidelines for the Communication of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop. 17th Annual Conference of the International Society for Exposure Analysis. October. Durham, North Carolina.

Speaker. 2007. Workshop on Childhood Asthma and Environmental Exposures at Indoor Swimming Pools. Advancing the Science. Fourth Annual World Aquatic Health™ Conference. 3 October. Cincinnati, Ohio.

LaKind, J.S., Berlin, C.M. Jr., Stokes J.L., Naiman, D.Q., Paul, I.M., Patterson, D.G. Jr., Jones, R.S., Niehüser, S., Park, A., Wang, R.Y., Needham, L.L., Lorber, M.N., Sjödin A. 2007. Lifestyle and polybrominated diphenyl ethers (PBDEs) in human milk in the United States: A pilot study. 17th Annual Conference of the International Society for Exposure Analysis. October. Durham, NC.

Invited speaker. 2007. Environmental chemicals and breastfeeding infants (update). La Leche League International’s 50th Anniversary Conference. July 23. Chicago.

2006

Invited speaker. 2006. Women’s & Children’s Health and the Environment. Talking about Environmental Chemicals in Human Milk: Why “Breast is Best.” April 24. Baltimore, Maryland.

Invited speaker. 2006. Grand Rounds. What is in mother’s milk and what does it mean? Environmental chemicals and breastfeeding infants. Children’s Hospital at Sinai. February 14. Baltimore, Maryland.

2005

LaKind, J.S., Berlin, C.M., Jr. 2005. Workshop on Human Milk Surveillance and Biomonitoring for Environmental Chemicals in the United States. 15th Annual International Society of Exposure Analysis Annual Meeting. November. Tucson, Arizona.

Invited speaker. 2005. Grand Rounds. Interpretation and communication of information from biomonitoring studies. What physicians should know. Maryland General Hospital. October 10. Baltimore, Maryland.

Invited speaker. 2005. Biomonitoring Panel Report: Biomonitoring study design, interpretation, and communication. International Society of Regulatory Toxicology and Pharmacology Workshop: Understanding Human Biomonitoring. June 16. Sacramento, California.

Invited speaker. 2005. What is in mother’s milk and what does it mean? Environmental chemicals and breastfeeding infants. Pediatric Academic Societies’ Annual Meeting, Perinatal Nutrition and Metabolism Club. May 16. Washington, DC.

Invited speaker. 2005. Interpretation and communication of information from biomonitoring Studies. chemicals in tissues—Biomonitoring. Ethics & Sustainability Dialogue Group. May 12. Alexandria, Virginia.

2004

Invited speaker. 2004. Breast Feeding Promotion Task Force. June 7. Baltimore, Maryland.

Invited speaker. 2004. What is in mother’s milk and what does it mean? A discourse on environmental chemicals and breastfeeding infants. Institute of Pharmacology and Toxicology, Section of Developmental and Environmental Toxicology, University of Zurich, April 22, Lausanne, Switzerland; World Health Organization, April 26, Geneva, Switzerland.

2003

LaKind, J.S., Susten, A., Mistry, K. 2003. Uses and interpretation of human biomonitoring data. Society for Risk Analysis Annual Meeting. December 10. Baltimore, Maryland.

Invited speaker. 2003. Environmental chemicals in human milk. Sixth National Environmental Public Health Conference. December 4. Atlanta, Georgia.LaKind, J.S., Bates, M.N., Wilkins, A.A. 2003. How useful is measurement of environmental chemicals in human milk in investigations of breast cancer etiology? Dioxin2003. August. Boston, MA.

Invited speaker. 2003. Department of Health and Human Services, Office on Women’s Health. Workshop on Breast Cancer and the Environment. June 26. Washington, DC.

Invited speaker. 2003. Chemicals and Risk: What You Should Know, What Patients May Ask. Grand Rounds, Hershey Medical Center, Penn State College of Medicine. April 8. Hershey, Pennsylvania.

Invited speaker. 2003. US Environmental Protection Agency’s Children’s Health Protection Advisory Committee. Research and surveillance of environmental chemicals in human milk. March 19. Washington, DC.

2002

Invited speaker. 2002. The Johns Hopkins University Bloomberg School of Public Health Education and Research Center Lecture Series. Environmental Chemicals in Human Milk. 2 December. Baltimore, Maryland.

Invited speaker. 2002. US Environmental Protection Agency Children’s Health and Protection Advisory Council Science and Regulatory Work Group. 15 October. Washington, DC.

Invited speaker. 2002. Breast milk monitoring for environmental chemicals in the U.S. Summary Expert Panel Workshop, Hershey, PA. Workshop on Chemicals and Drugs in Breast Milk. National Institutes of Health. April 24. Bethesda, Maryland.

2001

Pittinger, C.A., LaKind, J.S. 2001. Weighing ecological risks and societal benefits: Pharmaceuticals and personal care products in the environment. 22nd Annual Society of Environmental Toxicology and Chemistry Meeting. November 15. Baltimore, Maryland.

Invited speaker. 2001. Protocol for breast milk monitoring for environmental chemicals. Toxic Chemicals in Breast Milk: A National Workshop to Assess Hazards to Children’s Health of Chemical Contaminants in Breast Milk. Center for Children’s Health and the Environment, Mt Sinai School of Medicine. October 5. New York City, New York.

LaKind, J.S., Berlin, C.M. 2001. Developing a protocol for breast milk monitoring for environmental chemicals: Workshop overview. International Society of Exposure Analysis Annual Meeting. November 4-8. Charleston, South Carolina.

LaKind, J.S., Berlin, C.M., Naiman, D.Q. 2001. Infant exposure to chemicals in breast milk in the United States: What we need to learn from a breast milk monitoring program. Presented at the Children’s Environmental Health II: A Global Forum for Action. September 8. Washington, DC.

2000

LaKind, J.S., Berlin, C.M. 2000. PDBEs in breast milk: Where do we go from here? Dioxin2000. August 13-17. Monterey, California.

1999

LaKind, J.S., Berlin, C.M., Naiman, D.Q., Park, C.N. Characterization of dose distributions of selected breast milk contaminants to nursing infants: DDE and TCDD. American Public Health Association Annual Meeting, November, 1999; Society for Risk Analysis Annual Meeting, December, 1999; and Dioxin2000, Monterey, California, August 13-17, 2000.

1998

Invited speaker. 1998. Principles of toxicology. School Nurse Institute. August 5. Towson, Maryland.

Invited speaker. 1998. Alchemy, risk assessment, and other phenomena. Lawrence University Science Colloquium. April 17. Appleton, Wisconsin.

1997

Invited speaker. 1997. Managing risk in the face of scientific uncertainty. The Center for Technology, Environment, and Development (CENTED). Clark University. September 26. Worcester, Massachusetts.

1995

Williams, L.G., E. Fendick, J.S. LaKind, B. Stern, J.A. Strand, Tardiff, R.G. 1995. Risk-based water quality criteria for treated mine-tailings effluent. Second World Congress of the Society of Environmental Toxicology and Chemistry.

1994

Invited speaker. 1994. Comparison of human health risk assessment modeled data with observed data: Dioxin and lead. University of Guelph Department of Statistics. Guelph, Canada.

1993

Invited speaker. 1993. Morgan State University Chemistry Department. Lecture on aquatic chemistry concepts and environmental and regulatory applications.

1992

Invited speaker. 1992. National Association of Health Professionals Annual Conference.

1991

LaKind, J.S., Naiman, D.Q. 1991. Comparison of predicted and observed dioxin levels in fish: Implications for risk assessment. Society for Risk Analysis Annual Meeting.

LaKind, J.S., Rifkin, E. 1991. A coordinated approach to dioxin regulation. Presented at Dioxin: National Conference on Establishing Multimedia Controls. May, 1991. Washington, DC.

Invited speaker. 1991. Use of the BCF in criteria development for hydrophobic compounds. Virginia Water Pollution Control Association Annual Conference.

1990

LaKind, J.S., Rifkin, E. 1990. Current method for setting dioxin limits in water requires reexamination. Dioxin and PCBs: National Conference on Approaches to Address Human Health Risks and Aquatic Life Impacts. May, 1990. Washington, DC.

LaKind, J.S., Rifkin, E. 1990. Alternative approach for developing criteria for hydrophobic substances. 11th Annual Meeting of the Society of Environmental Toxicology and Chemistry.